Articles by Paul
-
New health care analyst/associate position open on our team
New health care analyst/associate position open on our team
By Paul McCracken
Activity
-
That's a wrap for summer research! However, Dr. Kari Dalnoki-Veress will still have to put up with me until April 2025 as I complete my Senior…
That's a wrap for summer research! However, Dr. Kari Dalnoki-Veress will still have to put up with me until April 2025 as I complete my Senior…
Liked by Paul McCracken
-
Yesterday was my last day at Cerevel Therapeutics. I was incredibly privileged to work with many talented, caring, and hardworking colleagues. I am…
Yesterday was my last day at Cerevel Therapeutics. I was incredibly privileged to work with many talented, caring, and hardworking colleagues. I am…
Liked by Paul McCracken
-
Thrilled to see Caitlin take this seat!
Thrilled to see Caitlin take this seat!
Liked by Paul McCracken
Experience
Education
Volunteer Experience
More activity by Paul
-
We were thrilled to welcome #AI and #machinelearning visionary Emily Fox to our team earlier this spring! Thank you Ron Leuty and San Francisco…
We were thrilled to welcome #AI and #machinelearning visionary Emily Fox to our team earlier this spring! Thank you Ron Leuty and San Francisco…
Liked by Paul McCracken
-
Happy to say that the CAP Congress opening event was a great success! I feel very fortunate to have been able to host this panel, allowing a number…
Happy to say that the CAP Congress opening event was a great success! I feel very fortunate to have been able to host this panel, allowing a number…
Liked by Paul McCracken
-
“In parallel to the AI revolution that was visible to many… there was a revolution that I think is not quite as visible to the general public – which…
“In parallel to the AI revolution that was visible to many… there was a revolution that I think is not quite as visible to the general public – which…
Liked by Paul McCracken
-
Sands Capital has added $555 million to the pool of capital available for private biotechs, medical device companies, diagnostics makers and others…
Sands Capital has added $555 million to the pool of capital available for private biotechs, medical device companies, diagnostics makers and others…
Liked by Paul McCracken
-
Happy to say I have completed my first week at the KDV Lab! Thank you to Dr. Kari Dalnoki-Veress and the team, who have made me feel welcome, and…
Happy to say I have completed my first week at the KDV Lab! Thank you to Dr. Kari Dalnoki-Veress and the team, who have made me feel welcome, and…
Liked by Paul McCracken
-
Fortunate to spend some time with Emily Fox today at a meeting on frontiers in the biosciences--with a focus on leveraging advances in AI models and…
Fortunate to spend some time with Emily Fox today at a meeting on frontiers in the biosciences--with a focus on leveraging advances in AI models and…
Liked by Paul McCracken
-
We are pleased to announce that Sunny Lee joined the Private Capital team, as Senior Director, Private Equity. Alongside our Private Equity team…
We are pleased to announce that Sunny Lee joined the Private Capital team, as Senior Director, Private Equity. Alongside our Private Equity team…
Liked by Paul McCracken
-
Delighted to announce my acceptance of a Research Experience Award to work with Dr Kari Dalnoki-Veress at McMaster University! I'm really looking…
Delighted to announce my acceptance of a Research Experience Award to work with Dr Kari Dalnoki-Veress at McMaster University! I'm really looking…
Liked by Paul McCracken
-
We are pleased to welcome Kathleen Bellehumeur as a Managing Director on our Private Equity team in Toronto. Kathleen will be responsible for…
We are pleased to welcome Kathleen Bellehumeur as a Managing Director on our Private Equity team in Toronto. Kathleen will be responsible for…
Liked by Paul McCracken
-
We’re delighted to announce the launch of our LV Edge Packaging System, which improves the cost efficiency and reduces the supply chain risk of…
We’re delighted to announce the launch of our LV Edge Packaging System, which improves the cost efficiency and reduces the supply chain risk of…
Liked by Paul McCracken
-
Since our inception more than five years ago, insitro has made significant strides toward unlocking transformative new medicines through our…
Since our inception more than five years ago, insitro has made significant strides toward unlocking transformative new medicines through our…
Liked by Paul McCracken
-
My latest on how BridgeBio Pharma has secured up to $1.25 billion in new financing from Blue Owl Capital and CPP Investments | Investissements RPC:…
My latest on how BridgeBio Pharma has secured up to $1.25 billion in new financing from Blue Owl Capital and CPP Investments | Investissements RPC:…
Liked by Paul McCracken
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Paul McCracken in Canada
8 others named Paul McCracken in Canada are on LinkedIn
See others named Paul McCracken